Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ORTIN LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ORTIN LABS ZYDUS LIFESCIENCES/
ORTIN LABS
 
P/E (TTM) x 34.2 -3.6 - View Chart
P/BV x 5.8 1.3 433.5% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ZYDUS LIFESCIENCES   ORTIN LABS
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
ORTIN LABS
Mar-23
ZYDUS LIFESCIENCES/
ORTIN LABS
5-Yr Chart
Click to enlarge
High Rs49532 1,566.3%   
Low Rs31917 1,924.1%   
Sales per share (Unadj.) Rs170.37.4 2,299.8%  
Earnings per share (Unadj.) Rs19.8-0.1 -17,105.6%  
Cash flow per share (Unadj.) Rs26.90.2 13,938.9%  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs173.013.4 1,294.9%  
Shares outstanding (eoy) m1,012.208.13 12,450.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.43.3 73.5%   
Avg P/E ratio x20.6-209.6 -9.8%  
P/CF ratio (eoy) x15.1125.2 12.1%  
Price / Book Value ratio x2.41.8 130.5%  
Dividend payout %30.30-   
Avg Mkt Cap Rs m412,144196 210,312.5%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5647 359,122.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37460 286,335.5%  
Other income Rs m4,7460 1,130,000.0%   
Total revenues Rs m177,12061 292,180.8%   
Gross profit Rs m29,6775 600,749.0%  
Depreciation Rs m7,2273 289,080.0%   
Interest Rs m1,2994 32,803.0%   
Profit before tax Rs m25,897-1 -2,333,063.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8780 -3,457,647.1%   
Profit after tax Rs m20,019-1 -2,129,680.9%  
Gross profit margin %17.28.2 209.8%  
Effective tax rate %22.715.2 149.1%   
Net profit margin %11.6-1.6 -746.9%  
BALANCE SHEET DATA
Current assets Rs m100,08265 153,100.8%   
Current liabilities Rs m55,26770 79,179.1%   
Net working cap to sales %26.0-7.4 -352.7%  
Current ratio x1.80.9 193.4%  
Inventory Days Days5016 306.4%  
Debtors Days Days942,072 4.5%  
Net fixed assets Rs m144,776147 98,749.1%   
Share capital Rs m1,01281 1,244.6%   
"Free" reserves Rs m174,14627 636,964.2%   
Net worth Rs m175,158109 161,213.1%   
Long term debt Rs m030 0.0%   
Total assets Rs m244,940212 115,554.1%  
Interest coverage x20.90.7 2,898.8%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.70.3 247.8%   
Return on assets %8.71.4 609.3%  
Return on equity %11.4-0.9 -1,326.7%  
Return on capital %15.52.1 751.0%  
Exports to sales %39.20-   
Imports to sales %11.90-   
Exports (fob) Rs m67,577NA-   
Imports (cif) Rs m20,544NA-   
Fx inflow Rs m67,5770-   
Fx outflow Rs m20,5440-   
Net fx Rs m47,0330-   
CASH FLOW
From Operations Rs m26,888-3 -1,062,766.8%  
From Investments Rs m11,712NA 14,640,000.0%  
From Financial Activity Rs m-44,0049 -486,769.9%  
Net Cashflow Rs m-5,3387 -81,001.5%  

Share Holding

Indian Promoters % 75.0 7.4 1,018.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 0.0 -  
FIIs % 5.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 92.6 27.0%  
Shareholders   306,495 12,314 2,489.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs ORTIN LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs ORTIN LABS Share Price Performance

Period Cadila Healthcare ORTIN LABS S&P BSE HEALTHCARE
1-Day 0.57% 4.89% 1.18%
1-Month 7.77% -11.31% -0.75%
1-Year 107.52% 1.31% 61.82%
3-Year CAGR 32.30% -19.32% 18.16%
5-Year CAGR 24.52% 5.34% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the ORTIN LABS share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of ORTIN LABS the stake stands at 7.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of ORTIN LABS .

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

ORTIN LABS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of ORTIN LABS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.